Sublimity Therapeutics Limited
Summary
Sublimity Therapeutics Limited was set up on Saturday the 8th of April 2000. Their current partial address is Dublin, and the company status is Liquidation. The company's current directors have been the director of 23 other Irish companies between them; 10 of which are now closed. Sublimity Therapeutics Limited has 1 shareholder.
Sublimity

Credit Score
- Latest Credit Movement:
- Date of Last Movement:28/04/2024
- Latest Accounts Filed:29/10/2019
- Report Based On Accounts:31/12/2018
- Next Set of Accounts Due:30/09/2020
Credit Report
- Credit Report & Financials
- Company Printout Report
- Directors & Owners Report
- Bad Debt Judgments Report
- Mortgages Report
€9
Company Vitals
- Company Name:Sublimity Therapeutics Limited
- Time in Business:24 Years
- Company Number:325502
- Company Size:Medium Company
- Current Status:LIQUIDATION
- Website:www.sigmoidpharma.com
- Phone:+353 (0)1 5715333
- Principal Activity: ? [24.41] Manufacture of Basic Pharmaceutical Products
- May Trade As:Sublimity Therapeutics Ltd
- Disclaimer: Other Details
- Please note the 'other details' displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us
- Largest Company Shareholder:
- Registered Address:Dcu Alpha,
Innovation Campus Old Finglas Road,
Dublin 11 Ireland,
Dublin 11, Dublin, Ireland - RiskWatch: MEETING OF CREDITORS
Took place on 19/04/2021
€3
Directors
Purchase either the Standard Company Report or a Credit Report to view details on the directors of this company.
Documents
Document | Pages | Effective | Received | Buy |
---|---|---|---|---|
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 8 | 18/10/2024 | 11/11/2024 | |
Form E3: Liquidator`s Accounts of Acts & Dealings | 5 | 18/04/2024 | 27/05/2024 | |
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 10 | 18/04/2024 | 19/04/2024 | |
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 7 | 18/10/2023 | 18/10/2023 | |
Form E3: Liquidator`s Accounts of Acts & Dealings | 6 | 18/04/2023 | 12/06/2023 | |
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 7 | 18/04/2023 | 06/06/2023 | |
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 7 | 18/10/2022 | 03/11/2022 | |
Form E3: Liquidator`s Accounts of Acts & Dealings | 7 | 18/04/2022 | 24/05/2022 | |
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 9 | 18/04/2022 | 03/05/2022 | |
Form E2: Notice of Appointment of Liquidator(s) | 4 | 19/04/2021 | 28/04/2021 | |
B1 ANNUAL RETURN | 20 | 30/09/2019 | 29/10/2019 | |
AMENDED CONSTITUTION | 20 | 14/09/2018 | 19/09/2018 | |
Migrated Certificate | 1 | null | 03/04/2000 |